Article from Psychiatry Advisor: Ketamine was originally approved by the US Food and Drug Administration (FDA) as an anesthetic, but is increasingly being used to treat mood disorders, such as treatment-resistant depression, anxiety disorders, and...
MONDAY, Feb. 7, 2022 (HealthDay News) — A new clinical trial strengthens the case that ketamine — once famous as a club drug — can rapidly ease suicidal thoughts. Researchers found that among 156 adults hospitalized for severe suicidal thoughts,...
Researchers at Cincinnati Children’s Hospital Medical Center have concluded that intranasal ketamine is as effective as intranasal fentanyl for the relief of pain from acute extremity injury in children. The findings from a recently completed randomized trial are...
The results of a new clinical trial with ketamine were published in Nature’s Molecular Psychiatry journal. Researchers conducted a double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant...
The National Institute of Mental Health (NIMH) issued a highlight on ketamine for treating depression. The most commonly used antidepressants are largely variations on a theme; they increase the supply within synapses of a class of neurotransmitters believed to...
Researchers from the University of Minnesota and The Mayo Clinic found that ketamine caused an average decrease of 42% on the Children’s Depression Rating Scale(CDRS)—the most widely used rating scale in research trials for assessing the severity of depression and...
Researchers at Yale published a new study titled “Acute and Longer-Term Outcomes Using Ketamine as a Clinical Treatment at the Yale Psychiatric Hospital” in Clinical Psychiatry. In late 2014, Yale began providing ketamine as an off-label therapy on a...
